Rigel Pharmaceuticals, Inc. (RIGL) Social Stream
RIGEL PHARMACEUTICALS INC (RIGL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RIGL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 4 | $11 | $7 | $8.5 | $1.14 | 645.61% |
| 2022-03-02 | 4 | $11 | $7 | $8.25 | $1.14 | 623.68% |
| 2022-05-03 | 5 | $11 | $4 | $7.4 | $1.14 | 549.12% |
| 2022-05-05 | 5 | $11 | $4 | $7.2 | $1.14 | 531.58% |
| 2022-06-09 | 7 | $7 | $0.8 | $2.008 | $1.14 | 76.14% |
| 2022-07-25 | 7 | $7 | $0.8 | $2.15 | $1.14 | 88.6% |
| 2022-08-03 | 7 | $7 | $0.8 | $2.221 | $1.14 | 94.82% |
| 2022-10-11 | 7 | $15 | $0.8 | $3.678 | $1.14 | 222.63% |
| 2022-11-06 | 7 | $15 | $0.8 | $3.535 | $1.14 | 210.09% |
| 2022-12-02 | 7 | $15 | $0.8 | $3.478 | $1.14 | 205.09% |
| 2023-03-08 | 7 | $15 | $0.8 | $3.492 | $1.14 | 206.32% |
| 2023-03-09 | 7 | $15 | $1.2 | $4.325 | $1.14 | 279.39% |
| 2023-05-03 | 7 | $15 | $1.2 | $3.993 | $1.14 | 250.26% |
| 2023-08-02 | 6 | $15 | $1.2 | $4.158 | $1.14 | 264.74% |
| 2023-11-08 | 6 | $15 | $1.3 | $4.175 | $1.14 | 266.23% |
| 2023-11-09 | 6 | $15 | $1 | $4.041 | $1.14 | 254.47% |
The Trend in the Analyst Price Target
Over the past 25 months, RIGL's average price target has gone down $4.62.
RIGL reports an average of 231.15% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-08 | 7 | 15 | 0.8 | 3.492 | 1.790 | 95.08% |
| 2023-03-09 | 6 | 15 | 1.2 | 3.992 | 1.680 | 137.62% |
| 2023-03-09 | 6 | 15 | 1.2 | 4.325 | 1.680 | 157.44% |
| 2023-08-02 | 6 | 15 | 1.2 | 4.158 | 1.290 | 222.33% |
| 2023-11-09 | 6 | 15 | 1.0 | 4.041 | 0.817 | 394.61% |
RIGL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 2 | 0 | 4 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 25 months, RIGL's average broker recommendation rating worsened by 0.66.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RIGL as an investment opportunity.
- RIGEL PHARMACEUTICALS INC's average analyst price target is greater than 81.77% of all US stocks.
- In the context of all US stocks, RIGEL PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1799.92% of them.
- RIGEL PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1467.72% of stocks in the small market cap category.
- In terms of how RIGEL PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 1424.89% of that group.
In the Pharmaceutical Products industry, ANIP, SEEL, and SIGA are the three stocks most similar to RIGEL PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for RIGL? Use POWR Ratings for clearer insight into price direction.